Literature DB >> 15728927

Activity of cathelicidin peptides against Chlamydia spp.

Manuela Donati1, Korinne Di Leo, Monica Benincasa, Francesca Cavrini, Silvia Accardo, Alessandra Moroni, Renato Gennaro, Roberto Cevenini.   

Abstract

The in vitro activity of six cathelicidin peptides against 25 strains of Chlamydia was investigated. SMAP-29 proved to be the most active peptide, reducing the inclusion numbers of all 10 strains of Chlamydia trachomatis tested by > or =50% at 10 microg/ml. This peptide was also active against C. pneumoniae and C. felis.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728927      PMCID： PMC549261          DOI： 10.1128/AAC.49.3.1201-1202.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Structural features and biological activities of the cathelicidin-derived antimicrobial peptides.

Authors:  R Gennaro; M Zanetti
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 2.  Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.

Authors:  J T Grayston
Journal:  J Infect Dis       Date:  2000-06       Impact factor: 5.226

3.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 4.  Antimicrobial peptides of phagocytes and epithelia.

Authors:  T Ganz; J Weiss
Journal:  Semin Hematol       Date:  1997-10       Impact factor: 3.851

5.  Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.

Authors:  B Yasin; R I Lehrer; S S Harwig; E A Wagar
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 6.  Chlamydiae as pathogens: new species and new issues.

Authors:  R W Peeling; R C Brunham
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

7.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection.

Authors:  K A Brogden; V C Kalfa; M R Ackermann; D E Palmquist; P B McCray; B F Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes.

Authors:  B Skerlavaj; M Benincasa; A Risso; M Zanetti; R Gennaro
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

10.  Susceptibility of Chlamydia trachomatis to protegrins and defensins.

Authors:  B Yasin; S S Harwig; R I Lehrer; E A Wagar
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441
View more
  10 in total

1.  Recombinant Human Peptidoglycan Recognition Proteins Reveal Antichlamydial Activity.

Authors:  Pavel Bobrovsky; Valentin Manuvera; Nadezhda Polina; Oleg Podgorny; Kirill Prusakov; Vadim Govorun; Vassili Lazarev
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

Review 2.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra; Richard E Lee
Journal:  Nat Rev Microbiol       Date:  2011-01       Impact factor: 60.633

3.  Specific polymorphisms in the vitamin D metabolism pathway are not associated with susceptibility to Chlamydia trachomatis infection in humans.

Authors:  Esmée Lanjouw; Ivan Branković; Jolein Pleijster; Joke Spaargaren; Christian J P A Hoebe; Henk J van Kranen; Sander Ouburg; Servaas A Morré
Journal:  Pathog Dis       Date:  2016-02-10       Impact factor: 3.166

4.  The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis.

Authors:  Narae Park; Kinrin Yamanaka; Dat Tran; Pete Chandrangsu; Johnny C Akers; Jessica C de Leon; Naomi S Morrissette; Michael E Selsted; Ming Tan
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

5.  Activity of Cathelicidin Peptides against Simkania negevensis.

Authors:  Manuela Donati; Antonietta Di Francesco; Maria Di Paolo; Natascia Fiani; Monica Benincasa; Renato Gennaro; Paola Nardini; Claudio Foschi; Roberto Cevenini
Journal:  Int J Pept       Date:  2011-04-05

Review 6.  Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors.

Authors:  Leena Hanski; Pia Vuorela
Journal:  Microorganisms       Date:  2016-11-28

7.  Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum.

Authors:  Emma Peel; Yuanyuan Cheng; Julianne T Djordjevic; Denis O'Meally; Mark Thomas; Michael Kuhn; Tania C Sorrell; Wilhelmina M Huston; Katherine Belov
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

8.  Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae.

Authors:  Leena Hanski; Dominik Ausbacher; Terttu M Tiirola; Morten B Strøm; Pia M Vuorela
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

Review 9.  Natural Products for the Treatment of Chlamydiaceae Infections.

Authors:  Mika A Brown; Michael G Potroz; Seoh-Wei Teh; Nam-Joon Cho
Journal:  Microorganisms       Date:  2016-10-16

10.  Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.

Authors:  Chunfu Yang; Laszlo Kari; Lei Lei; John H Carlson; Li Ma; Claire E Couch; William M Whitmire; Kevin Bock; Ian Moore; Christine Bonner; Grant McClarty; Harlan D Caldwell
Journal:  mBio       Date:  2020-08-18       Impact factor: 7.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.